Approaches sponsors, CROs, and investigators can take from the DMD experience.
Michael G. Kelly, PhD
Advertisement
Chief Scientific Officer, CureDuchenne
Articles by Michael G. Kelly, PhD
Advertisement
Latest Updated Articles
Rare Disease Clinical Trials: Strategies Learned from Duchenne Muscular DystrophyPublished: October 14th 2022 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
3
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
4
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
